Company: IMG
Filing Date: 2025-07-21
Form Type: 10-K
Source: 0001641172-25-020300
Chunk: 9

Company: CIMG Inc.
Filing Date: 2025-07-21
Form: 10-K
Item: Item 1A
Chunk 9
---
 able
to use a material portion of our NOLs, and this could reduce our earnings and potentially affect the valuation of our stock.

Risks
Related to Our Business

Continued
innovation and the successful development and timely launch of new products are critical to our financial results and the achievement
of our growth strategy.

Our
primary focus is on developing maca-based products for the Asian market, targeting consumers for use at home, in the office, and in other
everyday settings. Our future success depends, largely, on our ability to implement these and our other growth strategies effectively.
However, the achievement of our growth strategy is dependent, among other things, on our ability to extend the product offerings of our
existing brands and introduce innovative new. Although we devote significant focus to the development of new products, including Maca
Peptide Coffee, Maca-Noni, Maca Wine, Maca Purified Powder, we may not be successful in developing innovative new products or our new
products may not be commercially successful. Additionally, our new product introductions are often time sensitive, and thus failure to
deliver innovations on schedule could be detrimental to our ability to successfully launch such new products and retain partners, in
addition to potentially harming our reputation and customer loyalty. If we fail to implement our growth strategies or if we invest resources
in growth strategies that ultimately prove unsuccessful, our sales and profitability may be negatively affected, which would materially
and adversely affect our business, financial condition and results of operations. Our financial results and our ability to maintain or
improve our competitive position will depend on our ability to effectively gauge the direction of our key marketplaces and successfully
identify, develop, manufacture, market and sell new or improved products and co-packing services in these changing marketplaces.

Our
future financial results are difficult to predict, and failure to meet market expectations for our financial performance or any publicly
announced guidance may cause the price of our stock to decline.

As
we and our industry evolve, we expect to face new challenges with respect to our introduction of innovative products and the changing
competitive landscape within the maca products industry. These challenges can occur at various stages, including design, supply chain
and sales cycle. Any public forecasts regarding the expected performance of our business and future operating results are forward-looking
statements subject to risks and uncertainties, including the risks and uncertainties described in our filings with the SEC and in our
other public statements, and necessarily reflect current assumptions and judgments that may prove incorrect